Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
Taysha Gene Therapies priced a public offering of 32,500,001 shares of common stock at $6.00 per share and pre-funded warrants to purchase 833,333 shares. The company expects gross proceeds of approximately $200.0 million, excluding the exercise of the underwriters' option to purchase an additional 5,000,000 shares.
Key figures
- Deal Value Usd
- 200000000
- Offering Price
- 6
- Warrant price
- 5.999
- Greenshoe shares
- 5000000
- Common shares offered
- 32500001
- Pre funded warrants offered
- 833333
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.